Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Drugs for Dermatophytosis Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Rx
  • 1.3.3 OTC
• 1.4 Market Segment by Application
  • 1.4.1 Global Drugs for Dermatophytosis Market Share by Application (2019-2025)
  • 1.4.2 Hospital
  • 1.4.3 Clinic
  • 1.4.4 Other
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Drugs for Dermatophytosis Market Size
  • 2.1.1 Global Drugs for Dermatophytosis Revenue 2014-2025
  • 2.1.2 Global Drugs for Dermatophytosis Sales 2014-2025
• 2.2 Drugs for Dermatophytosis Growth Rate by Regions
  • 2.2.1 Global Drugs for Dermatophytosis Sales by Regions 2014-2019
  • 2.2.2 Global Drugs for Dermatophytosis Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Drugs for Dermatophytosis Sales by Manufacturers
  • 3.1.1 Drugs for Dermatophytosis Sales by Manufacturers 2014-2019
  • 3.1.2 Drugs for Dermatophytosis Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Drugs for Dermatophytosis Revenue by Manufacturers (2014-2019)
  • 3.2.2 Drugs for Dermatophytosis Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Drugs for Dermatophytosis Market Concentration Ratio (CR5 and HHI)
• 3.3 Drugs for Dermatophytosis Price by Manufacturers
• 3.4 Key Manufacturers Drugs for Dermatophytosis Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Drugs for Dermatophytosis Market
• 3.6 Key Manufacturers Drugs for Dermatophytosis Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Rx Sales and Revenue (2014-2019)
  • 4.1.2 OTC Sales and Revenue (2014-2019)
• 4.2 Global Drugs for Dermatophytosis Sales Market Share by Type
• 4.3 Global Drugs for Dermatophytosis Revenue Market Share by Type
• 4.4 Drugs for Dermatophytosis Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Drugs for Dermatophytosis Sales by Application

6 United States

• 6.1 United States Drugs for Dermatophytosis Breakdown Data by Company
• 6.2 United States Drugs for Dermatophytosis Breakdown Data by Type
• 6.3 United States Drugs for Dermatophytosis Breakdown Data by Application

7 European Union

• 7.1 European Union Drugs for Dermatophytosis Breakdown Data by Company
• 7.2 European Union Drugs for Dermatophytosis Breakdown Data by Type
• 7.3 European Union Drugs for Dermatophytosis Breakdown Data by Application

8 China

• 8.1 China Drugs for Dermatophytosis Breakdown Data by Company
• 8.2 China Drugs for Dermatophytosis Breakdown Data by Type
• 8.3 China Drugs for Dermatophytosis Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Drugs for Dermatophytosis Breakdown Data by Company
• 9.2 Rest of World Drugs for Dermatophytosis Breakdown Data by Type
• 9.3 Rest of World Drugs for Dermatophytosis Breakdown Data by Application
• 9.4 Rest of World Drugs for Dermatophytosis Breakdown Data by Countries
  • 9.4.1 Rest of World Drugs for Dermatophytosis Sales by Countries
  • 9.4.2 Rest of World Drugs for Dermatophytosis Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Novartis
  • 10.1.1 Novartis Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Drugs for Dermatophytosis
  • 10.1.4 Drugs for Dermatophytosis Product Introduction
  • 10.1.5 Novartis Recent Development
• 10.2 Pfizer
  • 10.2.1 Pfizer Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Drugs for Dermatophytosis
  • 10.2.4 Drugs for Dermatophytosis Product Introduction
  • 10.2.5 Pfizer Recent Development
• 10.3 Sanofi-Aventis
  • 10.3.1 Sanofi-Aventis Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Drugs for Dermatophytosis
  • 10.3.4 Drugs for Dermatophytosis Product Introduction
  • 10.3.5 Sanofi-Aventis Recent Development
• 10.4 Merck
  • 10.4.1 Merck Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Drugs for Dermatophytosis
  • 10.4.4 Drugs for Dermatophytosis Product Introduction
  • 10.4.5 Merck Recent Development
• 10.5 Enzon Pharmaceuticals
  • 10.5.1 Enzon Pharmaceuticals Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Drugs for Dermatophytosis
  • 10.5.4 Drugs for Dermatophytosis Product Introduction
  • 10.5.5 Enzon Pharmaceuticals Recent Development
• 10.6 Bayer
  • 10.6.1 Bayer Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Drugs for Dermatophytosis
  • 10.6.4 Drugs for Dermatophytosis Product Introduction
  • 10.6.5 Bayer Recent Development
• 10.7 Astellas Pharma
  • 10.7.1 Astellas Pharma Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Drugs for Dermatophytosis
  • 10.7.4 Drugs for Dermatophytosis Product Introduction
  • 10.7.5 Astellas Pharma Recent Development
• 10.8 GSK
  • 10.8.1 GSK Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Drugs for Dermatophytosis
  • 10.8.4 Drugs for Dermatophytosis Product Introduction
  • 10.8.5 GSK Recent Development
• 10.9 Abbott
  • 10.9.1 Abbott Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Drugs for Dermatophytosis
  • 10.9.4 Drugs for Dermatophytosis Product Introduction
  • 10.9.5 Abbott Recent Development

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Drugs for Dermatophytosis Sales Channels
  • 11.2.2 Drugs for Dermatophytosis Distributors
• 11.3 Drugs for Dermatophytosis Customers

12 Market Forecast

• 12.1 Global Drugs for Dermatophytosis Sales and Revenue Forecast 2019-2025
• 12.2 Global Drugs for Dermatophytosis Sales Forecast by Type
• 12.3 Global Drugs for Dermatophytosis Sales Forecast by Application
• 12.4 Drugs for Dermatophytosis Forecast by Regions
  • 12.4.1 Global Drugs for Dermatophytosis Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Drugs for Dermatophytosis Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

Ringworm on the skin like athlete's foot (tinea pedis) and jock itch (tinea cruris) can usually be treated with non-prescription antifungal creams, lotions, or powders applied to the skin for 2 to 4 weeks.
In 2019, the market size of Drugs for Dermatophytosis is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Drugs for Dermatophytosis.

This report studies the global market size of Drugs for Dermatophytosis, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Drugs for Dermatophytosis sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Novartis
Pfizer
Sanofi-Aventis
Merck
Enzon Pharmaceuticals
Bayer
Astellas Pharma
GSK
Abbott

Market Segment by Product Type
Rx
OTC

Market Segment by Application
Hospital
Clinic
Other

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Drugs for Dermatophytosis status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Drugs for Dermatophytosis manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Drugs for Dermatophytosis are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025